Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
作者： Katrin Liffers , Katarina Kolbe , Manfred Westphal , Katrin Lamszus , Alexander Schulte
DOI: 10.1007/S11523-015-0372-Y
关键词:
摘要: … inhibition decreases the amount of EGFR/EGFRvIII mRNA and protein in EGFR-amplified … Reduced EGFR mRNA and protein expression as a consequence of HDAC inhibition has …
springer.com
sci-hub.se 参考文章(48)
Regina Fillbrandt, Katrin Lamszus, Ulrike Ulbricht, Philip Kunkel, Manfred Westphal, Dimitrios Stavrou, Marc A. Brockmann, Peter Bohlen, Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Research. ,vol. 61, pp. 6624- 6628 ,(2001)
Holly M. Martinson, John H. Sampson, Gary E. Archer, Gregory J. Riggins, Chad A. Glazer, Anita Lal, Henry S. Friedman, Mutant Epidermal Growth Factor Receptor Up-Regulates Molecular Effectors of Tumor Invasion Cancer Research. ,vol. 62, pp. 3335- 3339 ,(2002)
Morten Lund-Johansen, Rolf Bjerkvig, Darell D. Bigner, Peter A. Humphrey, Sandra H. Bigner, Ole-Didrik Laerum, Effect of Epidermal Growth Factor on Glioma Cell Growth, Migration, and Invasion in Vitro Cancer Research. ,vol. 50, pp. 6039- 6044 ,(1990)
Jessica E. Bolden, Melissa J. Peart, Ricky W. Johnstone, Anticancer activities of histone deacetylase inhibitors Nature Reviews Drug Discovery. ,vol. 5, pp. 769- 784 ,(2006) , 10.1038/NRD2133
Y J Kim, C B Greer, K R Cecchini, L N Harris, D P Tuck, T H Kim, HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene. ,vol. 32, pp. 2828- 2835 ,(2013) , 10.1038/ONC.2013.32
C A Del Vecchio, C P Giacomini, H Vogel, K C Jensen, T Florio, A Merlo, J R Pollack, A J Wong, EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms Oncogene. ,vol. 32, pp. 2670- 2681 ,(2013) , 10.1038/ONC.2012.280
Elke Bergmann-Leitner, Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] Current Pharmaceutical Design. ,vol. 15, pp. 730- 731 ,(2005) , 10.2174/138161208784246207
David A. Nathanson, Beatrice Gini, Jack Mottahedeh, Koppany Visnyei, Tomoyuki Koga, German Gomez, Ascia Eskin, Kiwook Hwang, Jun Wang, Kenta Masui, Andres Paucar, Huijun Yang, Minori Ohashi, Shaojun Zhu, Jill Wykosky, Rachel Reed, Stanley F. Nelson, Timothy F. Cloughesy, C. David James, P. Nagesh Rao, Harley I. Kornblum, James R. Heath, Webster K. Cavenee, Frank B. Furnari, Paul S. Mischel, Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. ,vol. 343, pp. 72- 76 ,(2014) , 10.1126/SCIENCE.1241328
Y Marie, AF Carpentier, AMP Omuro, M Sanson, J Thillet, K Hoang-Xuan, J-Y Delattre, None, EGFR tyrosine kinase domain mutations in human gliomas Neurology. ,vol. 64, pp. 1444- 1445 ,(2005) , 10.1212/01.WNL.0000158654.07080.B0
J. S. Ungerstedt, Y. Sowa, W.-S. Xu, Y. Shao, M. Dokmanovic, G. Perez, L. Ngo, A. Holmgren, X. Jiang, P. A. Marks, Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 673- 678 ,(2005) , 10.1073/PNAS.0408732102